Hypolipidemic effects of compositions comprising beta-glucogallin
OwnerMuhammed Majeed, Kalyanam Nagabhushanam +3inventors
InventorsMuhammed Majeed, Kalyanam Nagabhushanam, Lakshmi Mundkur, Shaheen Majeed, Anurag Pande
Life of this patent
Estimating the term…
Abstract
Disclosed are the hypolipidemic effects of a composition comprising at least 10% w/w or above of 1-O-galloyl-β-D-glucose (β-glucogallin). The composition is effective in reducing the circulating levels of total cholesterol, triglycerides, LDL, cholesterol:HDL ratio and increasing HDL levels. The invention also discloses a method for reducing absorption and bio-accessibility of lipids in mammals using the abovementioned composition.
Claims14
A method for reducing absorption and bio-accessibility of lipids in mammals, comprising step of administering effective dose of a composition comprising at least 10% w/w or above of 1-O-galloyl-β-D-glucose (β-glucogallin) to bring about a reduction in absorption and bio-accessibility of lipids.
A method for therapeutic management of hyperlipidemia in mammals, comprising step of administering effective dose of compositions comprising at least 10% w/w or above of 1-O-galloyl-β-D-glucose (β-glucogallin) to bring about the effect of lowering levels of circulating cholesterol, LDL, triglycerides and cholesterol:HDL ratio and increasing HDL levels in the blood of said mammals.
Dependencies are inferred from the claim text.